标题
Pioglitazone for the treatment of Alzheimer’s disease
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 26, Issue 1, Pages 97-101
出版商
Informa UK Limited
发表日期
2016-11-25
DOI
10.1080/13543784.2017.1265504
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice
- (2016) Junya Toba et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinical drug research in chronic central neurodegenerative disorders
- (2016) Thomas Müller et al. Expert Review of Neurotherapeutics
- Clinical drug research in chronic central neurodegenerative disorders
- (2016) Thomas Müller et al. Expert Review of Neurotherapeutics
- Efficacy of memantine hydrochloride once-daily in Alzheimer’s disease
- (2014) Alexander Kurz et al. EXPERT OPINION ON PHARMACOTHERAPY
- Transdermal rivastigmine in the treatment of Alzheimer’s disease: current and future directions
- (2014) Hamid Reza Amanatkar et al. Expert Review of Neurotherapeutics
- Efficacy and safety of galantamine treatment for patients with Alzheimer’s disease: a meta-analysis of randomized controlled trials
- (2014) Deqi Jiang et al. JOURNAL OF NEURAL TRANSMISSION
- TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial
- (2013) Allen D. Roses et al. Alzheimers & Dementia
- Alzheimer disease therapy—moving from amyloid-β to tau
- (2013) Ezio Giacobini et al. Nature Reviews Neurology
- PPAR /RXR -Induced and CD36-Mediated Microglial Amyloid- Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice
- (2012) M. Yamanaka et al. JOURNAL OF NEUROSCIENCE
- Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor- -Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease
- (2012) S. Mandrekar-Colucci et al. JOURNAL OF NEUROSCIENCE
- Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
- (2011) C. Harrington et al. Current Alzheimer Research
- The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment
- (2011) Jae Hoon Moon et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Progress in Alzheimer’s disease
- (2011) Daniela Galimberti et al. JOURNAL OF NEUROLOGY
- Epidemiology of Alzheimer disease
- (2011) Christiane Reitz et al. Nature Reviews Neurology
- A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
- (2010) David S. Geldmacher et al. ARCHIVES OF NEUROLOGY
- How does diabetes accelerate Alzheimer disease pathology?
- (2010) Catrina Sims-Robinson et al. Nature Reviews Neurology
- APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure
- (2009) Lynn M. Bekris et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
- (2008) G. J. Ko et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started